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compared with those of manual cleaning and disinfection, which include chlo-
ride such as slightly acidic hypochlorous acid water or titanium dioxide. Of
them, Bio-Kil (Cargico Group, Taiwan) is a platform nanotechnology with con-
struction of quaternary ammonium compound to create a covalent or ionic
bond and embedded into the surfaces of environment, forming a durable
copolymer with a physical bactericidal property. A pilot study in intensive
care units had shown that the BIO-Kil treatment can inhibit the growth of bac-
teria and evidently suppress its colonization from 49.62 to 10.38 CFU/10 cm2.
Today we will present further study of its effectiveness on controlling the
colonization of MDROs in the hospital settings. Together with hand hygiene
campaign and other infection control bundles, there is a new horizon for us
to achieve the zero tolerance of HAIs in the 21st century.SP 20-3
PROACTIVE INFECTION CONTROL MEASURES TO PREVENT NOSOCOMIAL
TRANSMISSION OF VRE
Vincent C. C. Cheng a,b, S. C. Wong b, K. Y. Yuen b. aInfection Control Team,
Queen Mary Hospital, Hong Kong Special Administrative Region;
bDepartment of Microbiology, The University of Hong Kong, Hong Kong
Special Administrative Region
We adopted a multifaceted assertive proactive infection control approach
to minimize the nosocomial transmission and outbreak of VRE in a non-
endemic area. Active surveillance culture, extensive contact tracing and
single room isolation with contact precautions, together with other
infection control measures, such as directly observed hand hygiene in
conscious patients before receiving meals and medications, stringent hand
hygiene during patient care practices, and environmental cleanliness are
essential in limiting intra- and inter-hospital transmission. With the
implementation of these infection control measures, the incidence of
nosocomial acquisition of VRE had significantly decreased from 0.46 per
10,000 patient-days to 0.10 per 10,000 patient-days (p < 0.001 under
Poisson assumptions).
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ANTIBIOTIC STEWARDSHIP
SP 21-1
BENEFITS OF ANTIMICROBIAL STEWARDSHIP IN HOSPITALS: EVIDENCE
FROM A RECENT COCHRANE REVIEW
Ian M. Gould. Department of Medical Microbiology, Aberdeen Royal
Infirmary, Foresterhill, Aberdeen, Scotland AB25 2ZN, United Kingdom
Antibiotic stewardship has been around now for several decades but has
received renewed focus as a means of slowing the development of antibiotic
resistance (AR). Cochrane reviews include only papers of sufficiently robust
methodology and at the date of the last review (2006) there were less than
100 published scientific papers so classified on Antibiotic Stewardship. In
recent years a greater proportion of published papers have been included
but almost all are from USA and Europe. The majority use interrupted time
series analysis, with about a quarter being randomised controlled trials.
Currently a new review is updating the data basis and I will include data from
many of these papers in this talk.
Restrictive interventions such as order forms and expert approval have a
more immediate effect than persuasive (educational) interventions such as
audit and academic detailing but the effects of both are well maintained
over at least 2 years. Most are delivered by multidisciplinary teams, followed
by ID/micro and pharmacists.
There is robust evidence that effective stewardship, leading to major
reduction (34-42%) in the use of key agents such as quinolones and
cephalosporins can reduce Clostridium difficile infection, MRSA, VRE and
multi resistant Gram negatives by 24-68%. Lessons can be learnt from this
data for the control of carbapenemases. Also, improved quality of
use can reduce mortality from CAP. No associated increases in
mortality, length of stay or infection specific re-admission have been
documented.
In summary, antibiotic stewardship has a valuable role to play, alongside
hand hygiene and surveillance/cohorting/isolation/suppression/decoloniza-
tion in the control of Multi-Drug Resistant Organisms (MDROs).SP 21-2
SCALING UP EVIDENCE-BASED INTERVENTIONS TOWARD
SUSTAINABILITY: A CASE STUDY OF ANTIBIOTICS SMART USE PROGRAM
IN THAILAND
Nithima Sumpradit a, Trithape Fongthong b, Somying Pumtong c,
Siritree Suttajit d, Niyada Kiatying-Angsulee e. aFood and Drug
Administration, Ministry of Public Health, Thailand; bNational Health
Security Office, Thailand; cFaculty of Pharmacy, Srinakharinwirot
University, Nakhon Nayok, Thailand; dFaculty of Pharmacy, Chiang Mai
University, Chiang Mai, Thailand; eDrug System Monitoring and
Development Program, Chulalongkorn University, Bangkok, Thailand
Purpose: The ability to scale up health programs after the pilot project or
seeding funds ended has gained interest from health professionals, policy
makers and funders. Lessons learned from the Antibiotics Smart Use (ASU)
program might be useful. ASU aims at reducing antibiotic use in upper respi-
ratory infection, acute diarrhea and simple wound. Phase I tests interven-
tions (2007-8). Phase II assesses scaling-up feasibility (2008-9). Phase III
scales up ASU toward sustainability to achieve new social norms (2010-pre-
sent). The study aims at investigating ASU diffusion, scaling-up measures
and factors contributing to ASU adoption and sustainability.
Methods: ASU diffusion and factors regarding ASU adoption was assessed by
a mailed, self-administered survey for all hospitals. Scaling-up measures and
factors contributing to ASU continuity were assessed using previous ASU
evaluation research and in-depth interviews of 50 key informants from 15
ASU settings. Data were collected during MayeOctober 2014.
Results: Of 625 hospitals (response rate 52%), 91% were aware of ASU and
72% implemented ASU. The ASU adoption rate was 3% in 2008 and increased
to 17%, 25% and 27% during 2010-2012. Scaling up started with a model devel-
opment and followed by horizontal and vertical scaling-up measures. Hori-
zontal measures included building decentralized networks to promote
local ownerships. Vertical measures focused on integrating ASU into national
policies. The pay-for-performance policy by the National Health Security Of-
fice in 2009 greatly induced scaling-up. Factors involving ASU adoption
included to solve irrational use of medicines, to do the right thing, and to
improve quality of care. ASU continuity required ASU prime mover(s), man-
agement in hospitals, and external factors especially national policies.
Conclusion: ASU scaling-up starts with a model development and follows by
horizontal and vertical scaling-up measures. Despite limited resources, ASU
continues scaling up but its sustainability remains challenging as it needs
strong, long-term support from relevant national policies.SP 21-3
HOSPITAL INITIATIVES
Ching-Tai Huang. LinKou Chang Gung Memorial Hospital, Taiwan
No abstract.SP 21-4
AN INTERNATIONAL APPROACH TO ANTIMICROBIAL STEWARDSHIP:
EXAMPLE FROM VIETNAM
Heiman Wertheim, MD PhD. Oxford University Clinical Research Unit, Viet
Nam
Antimicrobial resistance is a major global health threat. In the European
Union an estimated 25,000 deaths occur annually secondary to multi-drug-
resistant infections. No reliable estimates for developing countries exist, but
figures are likely to be higher. Strategies to contain antimicrobial resistance
were comprehensively set forth by the World Health Organization (WHO) in
2001. However, implementation in low- and middle-income countries, where
the need for effective antimicrobials is greatest, has thus far proved
problematic [3],[4].
In Viet Nam, where resistance rates are among the highest in Asia, the
challenge is urgent and great. A large population, high infectious disease
burden, and unrestricted access to antimicrobials make Viet Nam a hotspot
for the emergence of drug resistance. Adequate legislation to tackle
antimicrobial resistance in Viet Nam already exists, but a lack of resources
prevents effective policy enforcement.
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provides opportunity to intervene. Interventions must account for limited
resources available in many regions with the highest resistance burdens. In
response to this we launched the Viet Nam Resistance (VINARES) project, a
capacity-building initiative designed to strengthen antimicrobial steward-
ship in Viet Nam. The framework of VINARES may be transferable to other
settings, and emerging economies in particular. During my talk I will present
our findings during the VINARES project.
Summary Points
 Antimicrobial stewardship has been difficult to implement globally, and
in emerging economies it is usually absent or inadequate.
 Implementation of antibiotic stewardship programmes need not wait
for “perfect local data” or funding. There is often sufficient local
expertise to start a programme in the absence of additional resources.
No immediate impact on resistance levels should be expected.
 Antibiotic resistance is partly the result of a dysfunctional health sys-
tem. Long-term commitment is necessary to improve healthcare infra-
structure in order to establish a successful antibiotic stewardship
programme and reduce resistance rates.
 Healthcare professionals, preferably “respected” figures, should coor-
dinate stewardship programmes. The programmes should be contex-
tualised and compatible with local practices to encourage
engagement and compliance of all healthcare workers.
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WHAT’S THE EVIDENCE FOR AND AGAINST USE OF CHORHEXIDINE FOR
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DOSE CVC CARE BUNDLE WORK IN CENTRAL LINE ASSOCIATED BLOOD
STREAM INFECTION (CLABSI)? e TAKE TAIWAN AS AN EXAMPLE
Chun-Ming Lee, MD. PhD. Division of Infectious Diseases, Department of
Internal Medicine, Infection Control Center, Mackay Memorial Hospital,
Taipei, Taiwan; Chairman of infection Control Society of Taiwan, Taiwan
Central line associated bloodstream infection (CLABSI) is an important issue in
healthcare associated infection (HAI). Theuse of catheter is an inevitable device
in hospital. According to the data of Taiwan Nosocomial Infection Surveillance
(TNIS), bloodstream infection ( BSI )is one of the most common HAI in intensive
care unit (ICU) and above 70% are associated with the use of catheter. This
presentation is to show the result of central venous catheter (CVC) care bundle
campaign in preventing CLABSI in the past four years in Taiwan.
The CVC care bundle campaign had two stages .The first stage belonged to
pilot study that initiated from 2010 to 2012. There were 26 ICU with 432 beds
from 14 hospitals of different areas of Taiwan. The second stage was called
promoted stage, started from 2013 to 2014 that included 50 hospitals with
133 ICU and 1900 beds. The data collection of CLABSI rate included before
and after CVC care bundle intervention. The contents of CVC care bundle
included 5 elements and two checklists of insertion and daily care of CVC.
The definition of CLABSI is at least one significant positive blood culture with
central catheter in situ or within 48 hours after catheter removing and had
to exclude the secondary BSI.
The CLABSI rate in the pilot study was 5.810/00 and 5.16
0/00 before and af-
ter intervention with 11.2% reduction only. The result showed 46 CLABSI
were avoided and it estimated 23,000 USD medical cost was saved (Ex-
tra-medical cost is about 5,000 USD per one CLABSI in Taiwan). At the sec-
ond stage the CLABSI rate was declined from 5.610/00 to 3.33
0/00 before
and after 19 months intervention with 40.6% reduction. The result showed
643 CLABSI were avoided and it estimated 3,215,000 USD medical cost was
saved.
Currently, there are some evidence based guidelines concerning the good
prevention of CLABSI by CVC care bundle (usually decreased 40e60%). Our
result 40.6% is approached to the low margin that reported by the
references. The important reasons are the compliance and consistency to
the care bundle is not so satisfactory that included the high femoral site
insertion, failure to scrub the hub in sufficient time and also high CVC
utilization rate. These will be emphasized in the further CVC quality
promotion campaign when more hospitals will be recruited.Keyword: Intensive care unit, central venous catheter, central line associ-
ated infection, care bundle
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USE OF CHLORHEXIDINE TO PREVENT SURGICAL SITE INFECTIONS
Keita Morikane. Division of Clinical Laboratory and Infection Control,
Yamagata University Hospital, Yamagata, Japan
The effectiveness of chlorhexidine (CHG) over iodophor (IP) has been
extensively investigated and demonstrated for the prevention of catheter-
associated bloodstream infection. However, its effectiveness toward the
prevention of surgical site infection (SSI) is controversial.
Numerous researches have been performed to address this profound
question to perform the meta-analysis. However, there are many barriers
which prevent us from doing it. First, there are many types of antiseptics
available for preoperative skin preparation: CHG, CHG-alcohol, aqueous
IP, IP-alcohol, etc. with various concentrations (0.5%, 1%, 2%, etc.).
Second, the effectiveness of specific skin preps is expected to vary
depending on the type of operation, i.e, whether it is a clean surgery of
clean-contaminated one. Third, the outcomes of the studies are different
from each other, i.e., whether it is incisional SSI only, or incisional and
organ space SSI.
The Writing Committee of the Updated CDC/HICPAC SSI Prevention Guideline
carefully examined the available evidence with regard to this area, and did
the systematic review and analysis comparing CHG with IP by adjusting other
factors such as addition of alcohol and number of prep-steps. Their review
resulted in hardly any difference in comparison of CHG with IP. The
drawback of their review is that they did not separate clean surgery and
clean-contaminated surgery.
Noorani et al. did the meta-analysis using data from the clean-contaminated
surgery (Noorani A, et al. Br J Surg 2010;97:1614-20), and found that CHG is
superior to IP in preventing SSI (OR 0.68, 95% CI: 0.50-0.94). However, the
addition of alcohol to the antiseptics varied among the studies included in
this meta-analysis.
Further study is needed to examine the effectiveness of CHG over IP.SP 22-3
PREVENTION OF VENTILATOR-ASSOCIATED PNEUMONIA
Glenys Harrington, RN, RM. Infection Control Consultancy (ICC), Melbourne,
Australia
Ventilator associated pneumonia (VAP) is associated with significant mor-
tality, increased length of stay and increased costs of care.
While the true incidence of VAP has been difficult to establish due to
surveillance definitions and methods and other serious complications
associated with mechanical ventilation such as acute respiratory distress
syndrome, it is estimated that up to fifty-five percent of VAP cases may be
preventable with the implementation of current practice guidelines/
recommendations.
In the US it has been estimated that if best practices were applied in all
hospitals the number of avoidable/preventable VAP infections would range
from 95,526 - 137,613 per annum and that 13,667 - 19,782 lives could be
saved.
Current basic practice guidelines/recommendations in the adult settings
include; avoiding intubation if possible, minimising sedation, maintaining
and improving physical conditioning, minimising pooling of secretions above
the endotracheal tube cuff, elevation of the head of the bed and
maintenance of ventilator circuits. In addition there are special approaches
or interventions in the settings where a hospital VAP rates are not reducing
despite demonstrated high compliance with basis practices. These addi-
tional approaches may have insufficient data at this point in time to
determine the impact on mortality, duration of mechanical ventilation and
length of stay.
Strategies to implement guidelines/recommendations including the “four
Es”; engagement, education, execution and evaluation will be discussed
along with current practice guidelines/recommendations to improve their
use at the bedside.
